Insider Trades Fuel Investor Interest: Uncovering 3 Hot Stocks $7M Bet On Ocular Therapeutix? Check Out These 3 Stocks Insiders Are Buying

Stocks in the U.S. market had a mixed closing on Tuesday, yet the insider trades offered a glimpse of optimism.

Insider transactions, when scrutinized closely, reveal more than just numbers. They unveil the confidence insiders have in the company’s future or sometimes signify a belief that the stock is undervalued. An insider purchase can be the beacon that guides investors, hinting at a golden opportunity waiting to be seized.

Let’s delve into the recent notable insider trades to decipher the underlying signals. For more insider scoops, be sure to hit up Benzinga’s very own insider transactions platform.

Insider Trade: V.F. Corporation

The Move: V.F. Corporation VFC Director Richard Carucci bagged 20,000 shares at an average price of $15.53, totaling around $310,620.
In the Limelight: VF Corp welcomed Caroline Brown on board after a rendezvous with Engaged Capital.
What V.F. Corporation Engages In: VF crafts, manufactures, and disperses branded apparel, footwear, and accessories.

Insider Trade: Western Midstream Partners

The Move: Western Midstream Partners, LP WES Director Kenneth F. Owen snatched up 7,000 shares at an average price of $33.96, amounting to $237,720.
What’s Brewing: In its latest quarterly report, Western Midstream Partners showcased a surge in year-over-year revenue outcomes.
What Western Midstream Partners Is All About: Western Midstream Partners LP is a U.S.-based entity that possesses, operates, procures, and advances midstream energy possessions.

Insider Trade: Ocular Therapeutix

The Move: Ocular Therapeutix, Inc. OCUL 10% owner Summer Road LLC purchased a whopping 930,851 shares at an average price of $7.52, tallying a hefty $7 million.
Latest Buzz: On February 22, Ocular Therapeutix unfurled a $325 million private placement initiative.
What Ocular Therapeutix Specializes In: Ocular Therapeutix Inc is a biotech trailblazer concentrating on eye therapies for a range of ocular diseases and conditions.